This inventor holds 2 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Innovations by Shin-etsu Kadowaki
Introduction
Shin-etsu Kadowaki is a notable inventor based in Murayama, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of influenza. With a total of 2 patents, Kadowaki's work showcases his dedication to advancing healthcare solutions.
Latest Patents
Kadowaki's latest patents focus on innovative treatments for influenza. The first patent presents a double-stranded RNA that inhibits the replication of influenza B viruses through RNA interference. This double-stranded RNA comprises an RNA with 19 to 25 nucleotides that are homologous to a part of an mRNA transcribed from the genomic RNA of the influenza B viruses, along with an antisense RNA. The second patent mirrors this innovation, emphasizing the importance of RNA interference in combating influenza B viruses.
Career Highlights
Throughout his career, Kadowaki has been associated with Kyorin Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His work has been instrumental in developing effective treatments for viral infections, particularly influenza.
Collaborations
Kadowaki has collaborated with notable colleagues, including Misako Nakazawa and Yoshiji Fujita. These partnerships have enhanced his research efforts and contributed to the success of his innovations.
Conclusion
Shin-etsu Kadowaki's contributions to the field of influenza treatment through his innovative patents highlight his role as a significant inventor in medical research. His work continues to pave the way for advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
